SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-20-000008
Filing Date
2020-04-22
Accepted
2020-04-22 07:12:33
Documents
16
Period of Report
2020-04-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q12020earnings8-k1.htm   iXBRL 8-K 37095
2 EXHIBIT 99.1 exhibit991-q12020press.htm EX-99.1 491112
8 biogenlogostandarda28.jpg GRAPHIC 756402
  Complete submission text file 0000875045-20-000008.txt   1724483

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20200331.xsd EX-101.SCH 4451
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20200331_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20200331_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20200331_lab.xml EX-101.LAB 26147
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20200331_pre.xml EX-101.PRE 13580
9 EXTRACTED XBRL INSTANCE DOCUMENT q12020earnings8-k1_htm.xml XML 4261
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 20806634
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences